Skip to main navigation

Contact Us

Investor Relations

Our Company
Product Candidates
- Pipeline
- MultiTAA Therapies
Our Science
Clinical Trials
- Active Clinical Trials
- Expanded Access Policy
Investors/Media
Careers

Investors/Media

Press Releases

Press Releases

Year

Feb 25, 2019

Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019

Feb 21, 2019

Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award

Feb 20, 2019

Marker Therapeutics to Present at the CAR-TCR Summit Europe

Feb 15, 2019

Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility

Feb 07, 2019

Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development

Feb 06, 2019

Marker Therapeutics to Present at the 2019 BIO CEO & Investor Conference

Jan 17, 2019

Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019

Jan 15, 2019

The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019

Jan 03, 2019

Marker Therapeutics Provides Updates of its Lead Clinical Programs

Dec 06, 2018

Marker Therapeutics to Present at the Tumor Targeted Lymphocytes Summit

Pagination

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Current page 12
Page 13
Next page
Last page

Displaying 111 - 120 of 126

Investors/Media

Investors/Media Home
News & Events
- Press Releases
- Events & Presentations
Stock Information
Financials & Filings
Corporate Governance
Investor Resources

IR and Media Contacts

investor.relations@markertherapeutics.com
(713) 400-6400

©2026 Marker Therapeutics, Inc. All Rights Reserved.

Footer Links

Sitemap
Terms of Use
Privacy Policy